Low-quality generics are being sold at U.S. pharmacies, despite the FDA’s best efforts. In this webinar, experts reveal why the system is failing and the steps needed to drive real change in the generic drug marketplace.
Featuring
– Peter Baker, President, Live Oak Quality Assurance and Former FDA Inspector
– Rosemary Gibson, Author, China Rx: Exposing the Risks of America’s Dependence on China for Medicine
– John Gray, PhD, Dean’s Distinguished Professor, Department of Operations and Business Analytics, Ohio State University
– Suzanne Robotti, Founder and President, MedShadow Foundation




If you feel like your generic drugs aren’t working, you may be right. Generics don’t alway...
Americans are waking up to the fact that we’ve been tolerating unacceptable failure rates ...
We think it’s invaluable — and hope you agree. Our work is made possible by donations from readers like you.
We think it’s invaluable — and hope you agree. Our journalism is made possible by donations from readers like you.
As a nonprofit, we don’t take a dime from pharmaceutical or supplement companies. That means we can report on the benefits, risks, and alternatives to prescription and over-the-counter drugs free from corporate pressure or influence.
No comments yet. Be the first to comment!